Maturitas
Volume 57, Issue 4 , Pages 405-414 , 20 August 2007

Black cohosh with or without St. John's wort for symptom-specific climacteric treatment—Results of a large-scale, controlled, observational study

  • Volker Briese

      Affiliations

    • Department of Gynecology at the Universitaets Klinikum Suedstadt, Suedring 81, D-18059 Rostock, Germany
    • ,
  • Ute Stammwitz

      Affiliations

    • Schaper & Brümmer GmbH & Co. KG, Bahnhofstrasse 35, D-38259 Salzgitter, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 5341 307520; fax: +49 5341 307524.
    • ,
  • Michael Friede

      Affiliations

    • Bardowickstrasse 34, D-28329 Bremen, Germany
    • ,
  • Hans-Heinrich Henneicke-von Zepelin

      Affiliations

    • Schaper & Brümmer GmbH & Co. KG, Bahnhofstrasse 35, D-38259 Salzgitter, Germany

Received 12 December 2006 ,Revised 25 April 2007 ,Accepted 26 April 2007.

References 

  1. Sherman S. Defining the menopausal transition. Am J Med. 2005;118(Suppl 2):3–7
  2. Schmidt PJ. Mood, depression, and reproductive hormones in the menopause transition. Am J Med. 2005;118:54–58
  3. Freedman RR. Hot flashes: behavioral treatments, mechanisms, and relation with sleep. Am J Med. 2005;118:124–130
  4. Dennerstein L, Burger H, Guthrie J. Sexuality. Am J Med. 2005;118:59–63
  5. McKinlay SM, Brambilla DJ, Posner J. The normal menopause transition. Maturitas. 1992;14:103–115
  6. Bair YA, Gold EB, Greendale GA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health. 2002;92:1832–1840
  7. Roussow JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  8. He K, Zheng B, Kim CH, Rogers L, Zheng Q. Direct analysis and identification of triterpene glycosides by LC/MS in black cohosh, Cimicifuga racemosa, and in several commercially available black cohosh products. Planta Med. 2000;66:635–640
  9. Hostanska K, Nißlein T, Freudenstein J, Reichling J, Saller R. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat. 2004;84(2):151–160
  10. Upton R, editor. American herbal pharmacopoeia and therapeutic compendium: Black Cohosh rhizome. Santa Cruz (CA): AHP; 2002.
  11. Linde K, Mulrow CD. St. John's wort for depression. Cochrane Database Syst Rev. 2000;2:CD000448
  12. Snow V, Lascher S, Mottur-Pilson C. Pharmacologic treatment of acute major depression and dysthymia. Ann Intern Med. 2000;132:738–742
  13. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105:1074–1083
  14. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD. Fixed combination of Black Cohosh and St. John's Wort Extracts for Climacteric Complaints. Obstet Gynecol. 2006;107:247–255
  15. Schneider HPG, Rosemeier HP, Schnitker J, Gerbsch S, Turck R. Application and analysis of the menopause rating scale (MRS) in a post-marketing surveillance study of Climen®. Maturitas. 2000;37:113–124
  16. Sickmüller B. Observational Studies – the German Expertise – BfArM—recommendations for the planning and implementation of observational studies. Regul Affairs J. 2004;12:247–250
  17. Schneider HPG, Heinemann LAJ, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric. 2000;3:50–58
  18. Foster EM. Propensity score matching—an illustrative analysis of dose response. Med Care. 2003;10:1183–1192
  19. Rosenbaum P. The central role of the propensity score in observational studies for causal effects. Biometrica. 1983;70:41–55
  20. Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988;
  21. North American Menopause Society . Recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause. 2004;11:589–600
  22. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO1055 vs. Conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 2003;44(Suppl 1):S67–S77
  23. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med. 2005;118:14S–24S
  24. Winterhoff H, Spengler B, Christoffel V, Butterweck V, Löhning A. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity. Maturitas. 2003;44:S51–S58
  25. Burdette JE, Liu J, Chen SN, et al. Black Cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51:5661–5670
  26. Dennerstein L, Dudley E, Hopper J, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–358
  27. Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause. 2003;10:465–476
  28. Low Dog T, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause. 2003;10:299–313
  29. Arold G, Donath F, Maurer A, et al. No relevant interaction with Alproazolam, Caffeine, Tolbutamide, and Digoxin by treatment with a low-hyperforin St. John's Wort extract. Planta Med. 2005;71:1–8
  30. Schröder D, Weiser M, Klein P. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: results of an observational cohort study. Eur J Heart Fail. 2003;3:319–326

PII: S0378-5122(07)00165-X

doi: 10.1016/j.maturitas.2007.04.008

Maturitas
Volume 57, Issue 4 , Pages 405-414 , 20 August 2007

Article Tools

* Image Usage & Resolution